Clinical Outcomes of Metachronous Recurrence of Gastric Epithelial Neoplasia Based on Helicobacter Pylori Infection Status and Microsatellite Stability

Overview

Journal Korean J Intern Med

Specialty General Medicine

Date 2022 May 5

PMID 35508936

Authors

Yeon-Ji Kim

Jaeyoung Kim

Woo Chul Chung

Affiliations

Soon will be listed here.

Abstract

Background/aims: Helicobacter pylori eradication may prevent the recurrence of gastric epithelial neoplasia after endoscopic treatment. However, H. pylori eradication therapy is unlikely to prevent gastric cancer. This study determined the longterm results and clinical outcomes of patients with gastric epithelial neoplasia based on H. pylori infection status and microsatellite stability (MSS).

Methods: Patients diagnosed with gastric epithelial neoplasia who underwent an endoscopic mucosal resection or submucosal dissection between 2004 and 2010 were included in this retrospective study. During the follow-up period (range, 4 to 14 years), disease recurrence was monitored, and tissue examinations were conducted for seven sets of microsatellite loci initially linked to the tumour suppressor gene locus. When H. pylori infection was identified, patients underwent eradication therapy.

Results: The patients (n = 120) were divided into three groups: H. pylori-negative with MSS, H. pylori-positive with MSS, and microsatellite instability (MSI). After H. pylori eradication, the rate of metachronous recurrence was significantly different in the MSI (28.2%) and MSS groups (3.7%, p < 0.01). The mean duration of recurrence was 77 months (range, 24 to 139) in the MSI group. There was no recurrence after eradication therapy in patients who were positive for H. pylori in the MSS group.

Conclusion: H. pylori eradication could help prevent gastric cancer recurrence in patients with stable microsatellite loci. Careful, long-term monitoring is required in patients with unstable microsatellite loci.

References

Velho S, Fernandes M, Leite M, Figueiredo C, Seruca R . Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol. 2014; 20(44):16433-42. PMC: 4248186. DOI: 10.3748/wjg.v20.i44.16433. View

Jung S, Park C, Kim E, Shin S, Chung H, Lee H . Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication. J Gastroenterol Hepatol. 2014; 30(1):75-81. DOI: 10.1111/jgh.12687. View

Leontiadis G, Ford A . Helicobacter pylori eradication: gastric cancer prevention. BMJ Clin Evid. 2015; 2015. PMC: 4668881. View

Kong Y, Yi H, Dai J, Wei M . Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol. 2014; 20(19):5903-11. PMC: 4024801. DOI: 10.3748/wjg.v20.i19.5903. View

Stolte M . The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch. 2003; 442(2):99-106. DOI: 10.1007/s00428-002-0680-3. View

Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Ushiku T . Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016; 84(4):618-24. DOI: 10.1016/j.gie.2016.03.791. View

Verma R, Agarwal A, Sakhuja P, Sharma P . Microsatellite instability in mismatch repair and tumor suppressor genes and their expression profiling provide important targets for the development of biomarkers in gastric cancer. Gene. 2019; 710:48-58. DOI: 10.1016/j.gene.2019.05.051. View

Xiao S, Li S, Zhou L, Jiang W, Liu J . Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis. J Gastroenterol. 2018; 54(3):226-237. DOI: 10.1007/s00535-018-1513-8. View

Lee H, Choi S, Lee H, Kim H, Yang H, Kang G . Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol. 2002; 15(6):632-40. DOI: 10.1038/modpathol.3880578. View

10.

Malfertheiner P . Gastric atrophy reversible or irreversible after Helicobacter pylori eradication - an open question. Digestion. 2011; 83(4):250-2. DOI: 10.1159/000321529. View

11.

Lee Y, Chiang T, Chou C, Tu Y, Liao W, Wu M . Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016; 150(5):1113-1124.e5. DOI: 10.1053/j.gastro.2016.01.028. View

12.

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H . Gastric cancer. Lancet. 2016; 388(10060):2654-2664. DOI: 10.1016/S0140-6736(16)30354-3. View

13.

Watari J, Tomita T, Tozawa K, Oshima T, Fukui H, Miwa H . Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Eradication and Aspirin. Gut Liver. 2019; 14(3):281-290. PMC: 7234884. DOI: 10.5009/gnl19079. View

14.

Park W, Lee S, Kim Y, Kim A, Park D, Lee B . Occurrence of metachronous or synchronous lesions after endoscopic treatment of gastric epithelia dysplasia- impact of histologic features of background mucosa. Pathol Res Pract. 2017; 214(1):95-99. DOI: 10.1016/j.prp.2017.10.022. View

15.

Fearon E . A genetic basis for the multi-step pathway of colorectal tumorigenesis. Princess Takamatsu Symp. 1991; 22:37-48. View

16.

Kim S, Lee S, Bae S, Jeong Y, Sohn S, Kim K . Association between status and metachronous gastric cancer after endoscopic resection. World J Gastroenterol. 2016; 22(44):9794-9802. PMC: 5124984. DOI: 10.3748/wjg.v22.i44.9794. View

17.

Lim J, Kim S, Choi J, Im J, Kim J, Jung H . Risk factors for synchronous or metachronous tumor development after endoscopic resection of gastric neoplasms. Gastric Cancer. 2014; 18(4):817-23. DOI: 10.1007/s10120-014-0438-z. View

18.

Murphy K, Zhang S, Geiger T, Hafez M, Bacher J, Berg K . Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn. 2006; 8(3):305-11. PMC: 1867601. DOI: 10.2353/jmoldx.2006.050092. View

19.

Nakata R, Nagami Y, Hashimoto A, Sakai T, Ominami M, Fukunaga S . Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis. Digestion. 2019; 102(2):236-245. DOI: 10.1159/000504132. View

20.

Venerito M, Malfertheiner P . Preneoplastic conditions in the stomach: always a point of no return?. Dig Dis. 2014; 33(1):5-10. DOI: 10.1159/000369185. View